Cargando…
Biodistribution and internal radiation dosimetry of a companion diagnostic radiopharmaceutical, [(68)Ga]PSMA-11, in subcutaneous prostate cancer xenograft model mice
[(68)Ga]PSMA-11 is a prostate-specific membrane antigen (PSMA)-targeting radiopharmaceutical for diagnostic PET imaging. Its application can be extended to targeted radionuclide therapy (TRT). In this study, we characterize the biodistribution and pharmacokinetics of [(68)Ga]PSMA-11 in PSMA-positive...
Autores principales: | Kim, Su Bin, Song, In Ho, Song, Yoo Sung, Lee, Byung Chul, Gupta, Arun, Lee, Jae Sung, Park, Hyun Soo, Kim, Sang Eun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316415/ https://www.ncbi.nlm.nih.gov/pubmed/34315965 http://dx.doi.org/10.1038/s41598-021-94684-6 |
Ejemplares similares
-
Preclinical
Evaluation of a Companion Diagnostic Radiopharmaceutical,
[(18)F]PSMA-1007, in a Subcutaneous Prostate Cancer Xenograft
Mouse Model
por: Kim, Su Bin, et al.
Publicado: (2022) -
(68)Ga-DOTA-DiPSMA PET/CT Imaging: Biodistribution, Dosimetry, and Preliminary Application in Prostate Cancer
por: Zhang, Jiaying, et al.
Publicado: (2022) -
[(68)Ga]Ga-PSMA-11: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
por: Hennrich, Ute, et al.
Publicado: (2021) -
Prospective of (68)Ga-Radiopharmaceutical Development
por: Velikyan, Irina
Publicado: (2013) -
Radiation dosimetry of [(68)Ga]PSMA-11 in low-risk prostate cancer patients
por: Sandgren, Kristina, et al.
Publicado: (2019)